Platinum-Resistant Ovarian Cancer Updates

Platinum-resistant ovarian cancer has historically been difficult to treat, but new trials are exploring a new class of drugs that researchers find encouraging. In this video, Dr. Kari Hacker, a gynecologic oncologist at the UNC Lineberger Comprehensive Cancer Center explains why results from the ROSELLA trial are meaningful for patients with platinum-resistant ovarian cancer. Disclaimer: […]

For decades, ovarian cancer treatment followed a familiar cycle: chemotherapy, remission, recurrence. For patients with platinum-resistant epithelial ovarian cancer, that can quickly become a frustrating cycle. Standard options narrow, responses shorten, and the search for something better becomes urgent. That urgency now has a credible answer. Folate Receptor-alpha (FR-α) is overexpressed in approximately 70% to […]

The landscape of ovarian cancer treatment is shifting. The Society of Gynecologic Oncology (SGO) Annual Meeting 2026 on Women’s Cancer, held April 10–13 in San Juan, Puerto Rico, delivered what researchers are calling transformative data across targeted therapies and resistant disease. Here are the top breakthroughs presented at this event. “Game changer” treatment combination for […]